8,150 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by OFI Invest Asset Management

OFI Invest Asset Management bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 8,150 shares of the medical equipment provider's stock, valued at approximately $4,108,000.

Other institutional investors also recently bought and sold shares of the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $31,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ISRG shares. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Remove Ads

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,209 shares of company stock worth $11,928,127. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

ISRG stock traded up $3.58 during mid-day trading on Wednesday, reaching $497.30. 2,557,102 shares of the company's stock were exchanged, compared to its average volume of 1,424,524. The company has a market cap of $177.13 billion, a price-to-earnings ratio of 77.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock's 50 day moving average is $569.42 and its 200 day moving average is $531.60. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.